TTK Healthcare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for TTK Healthcare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 17.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
TTK Healthcare (NSE:TTKHLTCARE) Has Affirmed Its Dividend Of ₹10.00
Jul 16TTK Healthcare (NSE:TTKHLTCARE) Is Paying Out A Dividend Of ₹10.00
Jul 02Estimating The Fair Value Of TTK Healthcare Limited (NSE:TTKHLTCARE)
Mar 04Is Now The Time To Put TTK Healthcare (NSE:TTKHLTCARE) On Your Watchlist?
Jun 04Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?
Mar 17Here's Why TTK Healthcare (NSE:TTKHLTCARE) Can Manage Its Debt Responsibly
Feb 22TTK Healthcare Limited (NSE:TTKHLTCARE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02A Look At TTK Healthcare's (NSE:TTKHLTCARE) Share Price Returns
Jan 19Our Take On TTK Healthcare's (NSE:TTKHLTCARE) CEO Salary
Jan 01Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?
Dec 16Is There More To The Story Than TTK Healthcare's (NSE:TTKHLTCARE) Earnings Growth?
Dec 01Is TTK Healthcare (NSE:TTKHLTCARE) A Risky Investment?
Nov 16Is The Market Rewarding TTK Healthcare Limited (NSE:TTKHLTCARE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Oct 21How Is TTK Healthcare's (NSE:TTKHLTCARE) CEO Paid Relative To Peers?
Sep 21Do These 3 Checks Before Buying TTK Healthcare Limited (NSE:TTKHLTCARE) For Its Upcoming Dividend
Aug 29TTK Healthcare's (NSE:TTKHLTCARE) Shareholders Are Down 36% On Their Shares
Aug 21Are Dividend Investors Getting More Than They Bargained For With TTK Healthcare Limited's (NSE:TTKHLTCARE) Dividend?
Jul 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TTK Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 7,713 | 799 | -155 | -8 | N/A |
6/30/2024 | 7,586 | 787 | N/A | N/A | N/A |
3/31/2024 | 7,528 | 628 | -153 | -49 | N/A |
12/31/2023 | 7,519 | 650 | N/A | N/A | N/A |
9/30/2023 | 7,506 | 641 | -302 | -148 | N/A |
6/30/2023 | 7,346 | 560 | N/A | N/A | N/A |
3/31/2023 | 7,251 | 447 | -365 | -248 | N/A |
12/31/2022 | 7,036 | 285 | N/A | N/A | N/A |
9/30/2022 | 6,798 | 226 | -96 | -39 | N/A |
6/30/2022 | 6,605 | 185 | N/A | N/A | N/A |
3/31/2022 | 5,992 | 185 | 395 | 450 | N/A |
12/31/2021 | 7,709 | 413 | N/A | N/A | N/A |
9/30/2021 | 7,376 | 368 | 496 | 543 | N/A |
6/30/2021 | 6,909 | 548 | N/A | N/A | N/A |
3/31/2021 | 4,761 | 368 | 947 | 964 | N/A |
12/31/2020 | 5,918 | 365 | N/A | N/A | N/A |
9/30/2020 | 5,784 | 333 | 796 | 855 | N/A |
6/30/2020 | 5,836 | 63 | N/A | N/A | N/A |
3/31/2020 | 6,458 | 123 | 76 | 198 | N/A |
12/31/2019 | 6,489 | 169 | N/A | N/A | N/A |
9/30/2019 | 6,321 | 173 | 131 | 212 | N/A |
6/30/2019 | 6,333 | 201 | N/A | N/A | N/A |
3/31/2019 | 6,279 | 244 | 130 | 173 | N/A |
12/31/2018 | 6,334 | 274 | N/A | N/A | N/A |
9/30/2018 | 6,313 | 348 | N/A | N/A | N/A |
6/30/2018 | 6,207 | 393 | N/A | N/A | N/A |
3/31/2018 | 5,775 | 182 | N/A | 253 | N/A |
12/31/2017 | 5,541 | 158 | N/A | N/A | N/A |
9/30/2017 | 5,126 | 126 | N/A | N/A | N/A |
6/30/2017 | 5,054 | 93 | N/A | N/A | N/A |
3/31/2017 | 5,278 | 187 | N/A | 178 | N/A |
12/31/2016 | 5,360 | 197 | N/A | N/A | N/A |
9/30/2016 | 5,399 | 234 | N/A | N/A | N/A |
6/30/2016 | 5,334 | 236 | N/A | N/A | N/A |
3/31/2016 | 5,189 | 227 | N/A | 374 | N/A |
12/31/2015 | 5,079 | 213 | N/A | N/A | N/A |
9/30/2015 | 5,012 | 182 | N/A | N/A | N/A |
6/30/2015 | 4,918 | 173 | N/A | N/A | N/A |
3/31/2015 | 4,829 | 162 | N/A | 394 | N/A |
12/31/2014 | 4,716 | 148 | N/A | N/A | N/A |
9/30/2014 | 4,565 | 141 | N/A | N/A | N/A |
6/30/2014 | 4,368 | 140 | N/A | N/A | N/A |
3/31/2014 | 4,162 | 124 | N/A | 127 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if TTKHLTCARE's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if TTKHLTCARE's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if TTKHLTCARE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if TTKHLTCARE's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if TTKHLTCARE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TTKHLTCARE's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/10 19:20 |
End of Day Share Price | 2025/01/10 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
TTK Healthcare Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Anil Burra | FirstCall Research |